SEC Comment Letter 0000000000-22-013502 to Surrozen, Inc./DE (SRZN)
Surrozen, Inc./DE
Date: Dec. 15, 2022 · CIK: 0001824893 · Accession: 0000000000-22-013502
AI Filing Summary & Sentiment
File numbers found in text: 333-268745
Letter
United States securities and exchange commission logo December 15, 2022 Craig Parker President and Chief Executive Officer Surrozen, Inc./DE 171 Oyster Point Blvd, Suite 400 South San Francisco, California 94080 Re:Surrozen, Inc./DE Registration Statement on Form S-3 Filed December 9, 2022 File No. 333-268745 Dear Craig Parker: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Daniel Crawford at 202-551-7767 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: John T. McKenna, Esq.
Show Raw Text
United States securities and exchange commission logo
December 15, 2022
Craig Parker
President and Chief Executive Officer
Surrozen, Inc./DE
171 Oyster Point Blvd, Suite 400
South San Francisco, California 94080
Re:Surrozen, Inc./DE
Registration Statement on Form S-3
Filed December 9, 2022
File No. 333-268745
Dear Craig Parker:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Daniel Crawford at 202-551-7767 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: John T. McKenna, Esq.